We use advanced molecular technologies to identify cells and genes expressed in the tissues of patients with neck pain that are associated with current and long-term pain.

Labeling physicians as providers reduces the patient–physician relationship to a commercial transaction

The last approved medication was pregabalin, over 20 years ago

Chronic Pain Is a Hidden Epidemic, It’s Time for a Revolution, By Jennifer Kahn

This supplement to existing HEAL clinical research awards funds the training of early career individuals in clinical pain research. Our trainee is Abby Chiu.

Collaborator: Merck & Co., Inc

A collaboration with Ted Price (University of Texas at Dallas), Pat Dougherty (MD Anderson Cancer Center), and Christoph Hofstetter (University of Washington)

We use RNA sequencing from neck tissues and advanced phenotyping to identify new treatment targets for chronic pain.

Central sensitization in chronic pain conditions

Beasley JW, Roberts RG, Goroll AH. Promoting Trust and Morale by Changing How the Word Provider Is Used: Encouraging Specificity and Transparency. JAMA. 2021;325(23):2343–2344. doi:10.1001/jama.2021.6046

A proposal for multi-institutional efforts to understand the human neurobiology of pain and identify therapeutic targets